Sunday 24 November 2019

Quinacrine and Berberine as Antiviral Agents against Dengue and Zika Fever: In Silico Approach- Crimson Publishers

Quinacrine and Berberine as Antiviral Agents against Dengue and Zika Fever: In Silico Approach by Vivek Srivastava in OpenAccess Biostatistics & Bioinformatics: Crimson Publishers- Open Access Biostatistics & Bioinformatics journals


TDengue and Zika fever are mosquito-borne viral diseases that have rapidly spread in all over world. Currently there are no specific drugs for DENV and ZIKV infection. The recent outbreak of these viruses realized that there are major health risks, demands an enhanced surveillance and a need to develop novel drugs against them. Non-structural proteins NS5 and NS3 are essential for the replication of the flavi-viral RNA genome. Therefore its inhibition could be considered as a useful strategy for treatment of DENV and ZIKV infection. Quinacrine and Berberine had been docked with NS5-methyltransferase of Dengue virus and NS3 protein of ZIKV using Auto dock 4.2 tools. Quinacrine and Berberine showed binding affinity -6.83kcal/mol and -6.22kcal/mol with NS5-methyltransferase and -7.32kcal/mol and -8.03kcal/mol with NS3 protease of ZIKV, respectively. Observations discussion in review will be useful in designing single drug against both virus infections.

For more open access journals in Crimson Publishers please click on link: https://crimsonpublishersresearch.com/

No comments:

Post a Comment